Fulminant diabetes induced by PD-1 and PD-L1 inhibitors: what about glucose variability?
- PMID: 30506459
- DOI: 10.1007/s00592-018-1262-4
Fulminant diabetes induced by PD-1 and PD-L1 inhibitors: what about glucose variability?
Keywords: Alpha-cell pancreatic function; Anti-PD-1; Anti-PD-L1; Autoimmune diabetes; Beta-cell pancreatic function; Coefficient of variation for glucose; Diabetes mellitus; Exocrine pancreatic function; Flash glucose monitoring; FreeStyle Libre; Fulminant diabetes; Glucose variability; Immune checkpoint inhibitors side effects; Immunotherapy; Labile diabetes; Programmed cell death-1; Programmed death ligand 1.
Comment on
-
Nivolumab-induced fulminant type 1 diabetes (T1D): the first Italian case report with long follow-up and flash glucose monitoring.Acta Diabetol. 2019 Apr;56(4):489-490. doi: 10.1007/s00592-018-1246-4. Epub 2018 Oct 25. Acta Diabetol. 2019. PMID: 30361845 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials